Drug therapy reduces neuroblastoma tumour growth in pre-clinical investigation

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Centre have discovered a new drug combination that significantly hinders tumour growth in neuroblastoma, a childhood cancer. The study was presented today at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology (ASPHO)...

Read the whole article on

More from